FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

L. Perrigo Clindamycin Phosphate and Benzoyl Peroxide Recall

Clindamycin Phosphate and Benzoyl Peroxide Gel, 1

L. Perrigo Company · Allegan, MI

Risk level
Class II
Reported by FDA
Jan 25, 2017
Recall ID
D-0434-2017
Check your lot numberHow we source this data

Summary

L. Perrigo recalled Clindamycin Phosphate and Benzoyl Peroxide starting Dec 28, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0434-2017 on Jan 25, 2017. Reason: Microbial Contamination of Non-Sterile Product; small number of tubes may include the presence of mold on the cap. Status: Terminated.

Why it was recalled

Microbial Contamination of Non-Sterile Product; small number of tubes may include the presence of mold on the cap

Product description

Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 45 g tubes, Rx Only, Manufactured by Perrigo, Yeruham, Israel, Distributed by Perrigo, Allegan, MI --- NDC 45802-736-84, UPC 345802736840

Lot numbers, UPCs & expiration codes

080806 (exp 12/16) 080844 ( exp 12/16) 080963 (exp 12/16) 080999 ( exp 12/16) 0841 09 ( exp 03/17 084197 ( exp 03/17) 091 090 ( exp 1 0/17) 092319 (exp 11/17) 092399 ( exp 12/17) 092440 ( exp 12/17)

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0434-2017
Classification
Class II
Status
Terminated
Recall initiated
Dec 28, 2016
FDA report date
Jan 25, 2017
Quantity
162,534 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
L. Perrigo Company

Original FDA data

Every field from FDA enforcement report D-0434-2017, exactly as published.

Show all FDA fields
City
Allegan
State
MI
Status
Terminated
Country
United States
Event ID
76061
Address
515 Eastern Ave
Code information
080806 (exp 12/16) 080844 ( exp 12/16) 080963 (exp 12/16) 080999 ( exp 12/16) 0841 09 ( exp 03/17 084197 ( exp 03/17) 091 090 ( exp 1 0/17) 092319 (exp 11/17) 092399 ( exp 12/17) 092440 ( exp 12/17)
Postal code
49010-9070
Report date
Jan 25, 2017
Product type
Drugs
Recall number
D-0434-2017
Classification
Class II
Recalling firm
L. Perrigo Company
Product quantity
162,534 tubes
Termination date
Aug 22, 2017
Reason for recall
Microbial Contamination of Non-Sterile Product; small number of tubes may include the presence of mold on the cap
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 45 g tubes, Rx Only, Manufactured by Perrigo, Yeruham, Israel, Distributed by Perrigo, Allegan, MI --- NDC 45802-736-84, UPC 345802736840
Distribution pattern
Nationwide
Recall initiation date
Dec 28, 2016
Initial firm notification
Letter
Center classification date
Jan 17, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0434-2017, published Jan 25, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls